Orchidectomy increases the formation of prostanoids and modulates their role in the acetylcholine-induced relaxation in the rat aorta

Cardiovascular Research

Volumn 77, Issue 3, 2008, Pages 590-599

  Martorell, Aina ^a   Blanco Rivero, Javier ^a   Aras López, Rosa ^a   Sagredo, Ana ^a   Balfagón, Gloria ^a   Ferrer, Mercedes ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Endothelium; Male sex hormones; PGE2; PGF2 ; PGI2; Rat aorta; TXA2

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ACETYLCHOLINE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; FUREGRELATE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTACYCLIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTANOID; SEX HORMONE; THROMBOXANE A2; THROMBOXANE RECEPTOR BLOCKING AGENT; THROMBOXANE SYNTHASE INHIBITOR; TRANYLCYPROMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FATTY ACID SYNTHESIS; MALE; NONHUMAN; ORCHIECTOMY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; UPREGULATION; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA; BLOOD PRESSURE; CYCLOOXYGENASE 2; EPOPROSTENOL; HYDRAZINES; MALE; ORCHIECTOMY; PROSTAGLANDINS; RATS; RATS, SPRAGUE-DAWLEY; TESTOSTERONE; THROMBOXANE A2; VASODILATION;

EID: 38849157834     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvm059     Document Type: Article

References (55)

1. Isensee J, Witt H, Pregla R, Hetzer R, Rgitz-Zagrosek V, Ruiz-Noppinger P. Sexually dimorphic gene expression in the heart of mice and men. J Mol Med 2007; doi:10.1007/s0019-007-0240-z.
2. Gayet-Ageron A, Amamra N, Ringa V, Tainturier V, Berr C, Clavel-Chapelon F et al. Estimated numbers of postmenopausal women treated by hormone therapy in France. Maturitas 2005;52:296-305.
3. English KM, Steeds R, Jones TH, Channer KS. Testosterone and coronary heart disease: is there a link? QJM 1997;90:787-791.
4. Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev 2003;24:313-340.
5. Littleton-kearney M, Hurn PD. Testosterone as a modulator of vascular behavior. Biol Res Nurs 2004;5:276-285.
6. Martin KC Ng. New perspectives on Mars and Venus: unravelling the role of androgens in gender differences in cardiovascular biology and disease. Heart, Lung and Circulation 2007;16:185-192.
7. Larsen BA, Nordestgaard BG, Stender S, Kjeldsen K. Effect of testosterone on atherogenesis in cholesterol-fed rabbits with similar plasma cholesterol levels. Atherosclerosis 1993;99:79-86.
8. Bruck B, Brehme U, Gugel N, Hanke S, Finking G, Lutz C et al. Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 1997;17:2192-2199.
9. Alexandersen P, Haarbo J, Byrjalsen I, Lawaetz H, Christiansen C. Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res 1999;84:813-819.
10. Nathan L, Shi W, Dinh H, Mukherjee TK, Wang X, Lusis AJ et al. Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc Natl Acad Sci 2001;98:3589-3593.
11. Wu SZ, Weng XZ. Therapeutic effects of an androgenic preparation on myocardial ischaemia and cardiac function in 62 elderly male coronary heart disease patients. Chin Med J 1993;106:415-418.
12. Rosano GM, Leonardo F, Pagnotta P, Pelliccia F, Panina G, Cerquetani E et al. Acute anti-ischaemic effect of testosterone in men with coronary artery disease. Circulation 1999;99:1666-1670.
13. English KM, Steeds RP, Jones TH, Diver MJ, Channer KS. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study. Circulation 2000;102:1906-1911.
14. Békési G, Kakucs R, Varbiro S, Racz K, Sprintz D, Feher J et al. In vitro effects of different steroid hormones on superoxide anion production of human neutrophil granulocytes. Steroids 2000;65:889-894.
15. Yorek MA, Coppey LJ, Gellett JS, Davidson EP, Bing X, Lund DD et al. Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function. Am J Physiol 2002;283:1067-1075.
16. Tep-areenan P, Kendall DA, Randall MD. Mechanisms of vasorelaxation to testosterone in the rat aorta. Eur J Pharmacol 2003;465:125-132.
17. Jones RD, Hugh Jones T, Channer KS. The influence of testosterone upon vascular reactivity. Eur J Endocrinol 2004;151:29-37.
18. Blanco-Rivero J, Sagredo A, Balfagón G, Ferrer M. Orchidectomy increase expression and activity of Cu/Zn-superoxide dismutase, while decreases endothelial nitric oxide bioavailability. J Endocrinol 2006;190:771-778.
19. Henrion D, Dechaux E, Dowell FJ, Maclour J, Samuel JL, Levy BI et al. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2. Br J Pharmacol 1997;121:83-90.
20. Félétou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder. Am J Physiol Heart Circ Physiol 2006;291:985-1002.
21. Blanco-Rivero J, Cachofeiro V, Lahera V, Aras-Lopez R, Márquez-Rodas, Salaices M et al. Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats. Hypertension 2005;46:107-112.
22. FitzGerald GA, Healy C, Daugherty J. Thromboxane A2 biosynthesis in human disease. Fed Proc 1987;46:154-158.
23. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999;79:1193-1226.
24. Noll G, Luscher TF. The endothelium in acute coronary syndromes. Eur Heart J 1998;19:C30-C38.
25. Gonzales RJ, Ghaffari AA, Duckles SP, Krause DN. Testosterone treatment increases thromboxane function in rat cerebral arteries. Am J Physiol Heart Circ Physiol 2005;289:578-585.
26. 2 formation. J Vasc Res 2006;43:101-108.
27. 2 mediates contraction and relaxation of vascular smooth muscle. Am J Physiol 1994;267:H796-H803.
28. Rapoport RM, Williams SP. Role of prostaglandins in acetylcholine-induced contraction of aorta from spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 1996;28:64-75.
29. Gluais P, Lonchampt M, Morrow JD, Vanhoutte PM, Feletou M. Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin. Br J Pharmacol 2005;146:834-845.
30. Blanco-Rivero J, Balfagón G, Ferrer M. Male castration increases neuronal nitric oxide synthase activity in the rat mesenteric artery through protein kinase C activation. J Vasc Res 2005;42:526-534.
31. Nielsen KC, Owman C. Contractile response and amine receptor mechanisms in isolated middle cerebral artery of the cat. Brain Res 1971;27:33-42.
32. Ferrer M, Tejera N, Marín J, Balfagón G. Androgen deprivation facilitates acetylcholine-induced relaxation by superoxide anion generation. Clin Sci 1999;97:625-631.
33. Beato M, Klug J. Steroid hormone receptors: an update. Hum Reprod Update 2000;6:225-236.
34. Liu D, Dillon JS. Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha (i2,3). J Biol Chem 2002;277:21379-21388.
35. Simoncini T, Mannella P, Fornari L, Varone G, Caruso A, Genazzani AR. Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology 2003;144:3449- 3455.
36. Naseem KM. The role of nitric oxide in cardiovascular diseases. Mol Aspects Med 2005;26:33-65.
37. Blanco-Rivero J, Sagredo A, Balfagón G, Ferrer M. Protein kinase C activation increases endothelial nitric oxide release in mesenteric arteries from orchidectomized rats. J Endocrinol 2007;192:189-197.
38. 2-adrenoceptor reactivity. Endothelium 1998;6:133-141.
39. Briones AM, Alonso MJ, Hernanz R, Tovar S, Vila E, Salaices M. Hypertension alters the participation of contractile prostanoids and superoxide anions in lipopolysaccharide effects on small mesenteric arteries. Life Sci 2002;71:1997-2014.
40. Klein T, Eltze M, Grebe T, Hatzelmann A, Kömhoff M. Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition. Cardiovasc Res 2007;75:390-397.
41. Shimokawa H. Endothelial dysfunction in hypertension. J Atheroscler Thromb 1998;4:118-127.
42. Matz RL, de Sotomayor MA, Schott C, Stoclet JC, Andriantsitohaina R. Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. Br J Pharmacol 2000;131:303-311.
43. Nie D, Lamberti M, Zacharek A, Li L, Szekeres K, Tang K et al. Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis. Biochem Biophys Res Commun 2000;267:245-251.
44. Matsuda K, Ruff A, Morinelli TA, Mathur RS, Halushka PV. Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets. Am J Physiol 1994;267:887-893.
45. Ajayi AA, Halushka PV. Castration reduces platelet thromboxane A2 receptor density and aggregability. QJM 2005;98:349-356.
46. 2 receptors in cultured rat aortic smooth muscle cells. Prostaglandins 1995;49:183-196.
47. Higashiura K, Mathur RS, Halushka PV. Gender-related differences in androgen regulation of thromboxane A2 receptors in rat aortic smooth-muscle cells. J Cardiovasc Pharmacol 1997;29:311-115.
48. Schror K, Morinelli TA, Masuda A, Matsuda K, Mathur RS, Halushka PV. Testosterone treatment enhances thromboxane A2 mimetic induced coronary artery vasoconstriction in guinea pigs. Eur J Clin Invest 1994;24:50-52.
49. Karanian JW, Ramwell PW. Effect of gender and sex steroids on the contractile response of canine coronary and renal blood vessels. J Cardiovasc Pharmacol 1996;27:312-319.
50. 2. Science 2002;296:539-541.
51. Bachschmid M, Schildknecht S, Ullrich V. Redox regulation of vascular prostanoid synthesis by the nitric oxide-superoxide system. Biochem Biophys Res Commun 2005;338:536-542.
52. FitzGerald GA. Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists. Am J Cardiol 1991;68:11B- 15B.
53. 2. J Biol Chem 2001;276:37839-37845.
54. Blanco-Rivero J, Márquez-Rodas I, Xavier F, Aras-López R, Villa-Arroyo I, Ferrer M et al. Long-term fenofibrate treatment impairs endothelium-dependent dilation to acetylcholine by altering cyclooxygenase pathway. Cardiovas Res 2007;75:398-340.
55. Frein D, Schildknecht S, Bachschmid M, Ullrich V. Redox regulation: a new challenge for pharmacology. Biochem Pharmacol 2005;70:811-823.